1. Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani MH, Nakhaee N, Oroomiei N. Unveiling the roadblocks: exploring substance use disorder treatment policies in Iran through a qualitative lens. Addict Sci Clin Pract. 2024;19(1):80. [
DOI:10.1186/s13722-024-00511-4] [
PMID] [
PMCID]
2. Aghakhani N, Lopez V, Cleary M. Experiences and perceived social support among Iranian men on methadone maintenance therapy: a qualitative study. Issues Ment Health Nurs. 2017;38(9):692-97. [
DOI:10.1080/01612840.2017.1341586] [
PMID]
3. Gerra G, Manfredini M, Somaini L, Maremmani I, Leonardi C, Donnini C. Sexual dysfunction in men receiving methadone maintenance treatment: clinical history and psychobiological correlates. Eur Addict Res. 2016;22(3):163-75. [
DOI:10.1159/000441470] [
PMID]
4. Trajanovska AS, Vujovic V, Ignjatova L, Janicevic-Ivanovska D, Cibisev A. Sexual dysfunction as a side effect of hyperprolactinemia in methadone maintenance therapy. Med Arch. 2013;67(1):48-50. [
DOI:10.5455/medarh.2013.67.48-50] [
PMID]
5. Changchien TC, Hsieh TJ, Yen YC. Erectile dysfunction among male patients receiving methadone maintenance treatment: focusing on anxiety-related symptoms. Sex Med. 2024;12(4): qfae052. [
DOI:10.1093/sexmed/qfae052] [
PMID] [
PMCID]
6. Ramli FF, Shuid AN, Pakri Mohamed RM, Tg Abu Bakar Sidik TMI, Naina Mohamed I. Health-seeking behavior for erectile dysfunction in methadone maintenance treatment patients. Int J Environ Res Public Health. 2019;16(21):4249. [
DOI:10.3390/ijerph16214249] [
PMID] [
PMCID]
7. Bruneau J, Ahamad K, Goyer MÈ, Poulin G, Selby P, Fischer B, Wild TC, Wood E; CIHR Canadian Research Initiative in Substance Misuse. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247-E257. [
DOI:10.1503/cmaj.170958] [
PMID]
8. Motazedian S, Entezam S, Banihashem S, Zahed G, Kheradmand A. Erectile dysfunction in methadone maintenance therapy.Int J High Risk Behav Addict.2020;9(3):e100781. [
DOI:10.5812/ijhrba.100781]
9. Hammarlund R, Crapanzano KA, Luce L, Mulligan L, Ward KM. Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders. Subst Abuse Rehabil. 2018;9:115-136. [
DOI:10.2147/SAR.S183256] [
PMID] [
PMCID]
10. Medina II WA, Conermann T. Opioid-induced endocrinopathy. [Updated 2022 Nov 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559211/
11. Cai Z, Song X, Zhang J, Yang B, Li H. Practical approaches to treat ED in PDE5i nonresponders. Aging Dis. 2020;11(5):1202-1218. [
DOI:10.14336/AD.2019.1028] [
PMID] [
PMCID]
12. Durrani M, Bansal K. Methadone. [Updated 2024 Jan 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562216/